Editorial Policies

Aims and Scope

Consortium PSYCHIATRICUM is an international peer-reviewed medical science journal specializing in psychiatry.

Consortium PSYCHIATRICUM addresses its articles to a wide range of professionals in the field of mental health and related disciplines, including opinion leaders of the international scientific community, heads of professional psychiatric associations, scientists, researchers, teachers, doctoral students, graduate students, university students, practicing specialists.

The journal aims to create an open, international platform for covering the most relevant research in the field of mental health.

Objectives:

1. To publish high-quality and reliable research results using a rigorous selection of articles based on the criteria of novelty and relevance of the topic, originality, and accuracy of the data presented.
2. To implement up-to-date editorial standards, including Online First publication, open access to full-text versions of articles, and application of the EQUATOR Network publication guidelines.
3. To promote key research through the media and social networks, ensuring the dissemination of scientific achievements.
4. To comply with international ethical standards (COPE) at all stages of the publication process.

Mission:

Information
Consortium PSYCHIATRICUM is a global mental health knowledge ecosystem: we bring together scientists of various specialties, regions, and cultures to find answers to the most difficult mysteries of the human psyche.
Education
Consortium PSYCHIATRICUM is a navigator in the world of science: we attract leading researchers, use the state-of-the-art methods for reporting scientific results, and adhere to high publication standards.
Collaboration
Consortium PSYCHIATRICUM brings science to the world: we provide open access to scientific data, make the difficult language of science accessible, communicate findings to a wider audience, and give researchers the opportunity to make a name for themselves.

 
 

Peer Review Process

1. General Information

1.1. All manuscripts submitted to the Consortium PSYCHIATRICUM journal undergo a mandatory double-blind peer review process. This ensures anonymity for both authors and reviewers. Each manuscript is assessed by at least one specialist in a medical field relevant to the manuscript's topic.

1.2. For article types such as interviews, commentaries, and letters to the editor, the publication decision rests with the Editorial Board.

1.3. Peer review is conducted on a voluntary basis.

 
2. Reviewer Selection
2.1. The Deputy Editor-in-Chief handles reviewer selection for all manuscripts.

2.2. Reviewers are selected from the Editorial Board members and external experts, leading Russian and international specialists in the relevant medical field.

2.3. A reviewer must possess the requisite scientific qualifications, demonstrated by an academic degree not lower than Ph.D. and relevant publications within the last three years. The reviewer must be free from any scientific, financial, or other conflicts of interest with the authors.

2.4. Manuscripts authored by the Editor-in-Chief, Deputy Editor-in-Chief, scientific editors, or members of the Editorial Board are reviewed exclusively by external reviewers. The selection of reviewers in such cases is performed by an editor who is not involved in the conflict of interest.

2.5. Authors may suggest potential reviewers (typically no more than two) or indicate reviewers who should be excluded from the process. The editorial team will consider these requests, but the final selection remains the prerogative of the Deputy Editor-in-Chief.

 
3. Reviewer Responsibilities
Reviewers are required to:

3.1. Evaluate the intellectual content of the manuscript impartially and objectively, without regard to the authors' race, gender, sexual orientation, religion, origin, citizenship, or political preferences.

3.2. Promptly notify the journal if they feel unqualified to review the manuscript or are unable to meet the review deadline.

3.3. Treat the received manuscript as a strictly confidential document. They must not disclose its content or discuss it with third parties without explicit permission from the editors. Unpublished data must not be used for personal advantage without the author's written consent. All correspondence with the editorial office is confidential.

3.4. Provide clear, polite, constructive, and substantive feedback. Critique should be directed at the work's content, not the author personally.

3.5. Decline to review a manuscript in case of any conflict of interest (scientific, financial, or personal) that could bias their perception or interpretation of the work.

3.6. Identify significant publications on the manuscript's topic that are missing from the bibliography, as well as verify the presence of proper bibliographic citations for all previously published statements, observations, and conclusions used in the work. Upon detecting substantial similarity or textual overlap between the manuscript under review and any other published materials, the reviewer must promptly inform the editorial board of such findings.

4. Review Procedure
4.1. The editorial team sends reviewers an official request containing the anonymized manuscript, reviewer guidelines, and a standard peer review form. Reviewers are expected to accept or decline the invitation within three business days.

4.2. The standard review period is two weeks, which may be extended upon the reviewer's request.

4.3. The reviewer must assess the manuscript based on the following criteria: relevance, topicality, novelty, originality, practical significance, scientific value, adherence to publishing ethics, and clarity of presentation.

4.4. The reviewer completes the review form and may provide specific comments directly in the manuscript text using the "Track Changes" feature.

4.5. Based on the assessment, the reviewer provides one of the following recommendations:

  • Accept without changes;
  • Accept after minor revisions (small, specific corrections required);
  • Accept after major revisions (significant amendments to text required);
  • Reject (explaining the reason for the editors).
 
5. Manuscript Revision

5.1. The completed review and the manuscript are assessed by a scientific editor, who makes a preliminary decision on its suitability for publication.

5.2. If a reviewer or the scientific editor recommends rejection, the manuscript is forwarded to the Editorial Board for a final decision.

5.3. If revision is required, the authors receive the reviewers' and scientific editor's comments. Authors must revise the manuscript using the "Track Changes" feature or provide a reasoned rebuttal for any comment not addressed. A point-by-point response to all reviewers' comments must be provided in a separate document.

5.4. The revised manuscript is sent back to the reviewer for re-evaluation. This process is repeated until the reviewer recommends acceptance or the manuscript is rejected.

 
6. Guidelines for Reviewers on the Use of Artificial Intelligence
6.1. Prohibited use of AI by reviewers
Reviewers are strictly prohibited from uploading any part of a manuscript under consideration into public or non-secure generative AI tools. Such actions constitute a breach of peer review confidentiality and may lead to the unauthorized dissemination of unpublished data, including personal information. This also creates a significant risk of intellectual property infringement, as public AI platforms do not guarantee data protection or privacy.

6.2. Permitted use of AI by reviewers
Reviewers are permitted to use AI tools for the following tasks, provided no confidential manuscript content is disclosed:

  • Structuring or outlining a review report and prioritizing comments.
  • Performing language editing on a self-drafted review text (e.g., grammar checking, improving style and clarity, or translation).
  • Asking general, non-confidential questions about research methodologies or statistical analyses without revealing specific details, data, or results from the manuscript under review.

6.3. Required Actions and Reporting

  • Reviewers must obtain written permission from the editorial office or editor before using AI for any analysis of manuscript content or for purposes beyond the scope defined in section 6.2.
  • Reviewers must confidentially report to the editor any signs within a manuscript that suggest undisclosed use of AI for content generation, providing a detailed rationale for their concerns.

6.4. Assessment of AI Use in Manuscripts
The use of AI in manuscript preparation is not, in itself, grounds for rejection. However, reviewers must verify that the authors have properly declared such use in the manuscript, in accordance with the journal’s AI Policy.

6.5. Core Principles for Evaluating Manuscripts Prepared with AI
The primary focus of the review must remain on the research quality, integrity, clarity, and adherence to scientific standards, regardless of the tools used in preparation. The critical question shifts from "Was AI used?" to an assessment of:

  1. The manuscript's overall compliance with the journal’s scientific and editorial standards.
  2. The accuracy and completeness of any AI use declarations and their correspondence to the manuscript's actual content.

6.6. Actions Upon Detection of Potential AI Use

  • If a reviewer identifies potential undisclosed AI-generated content (e.g., non-existent references, generic prose, superficial analysis, contradictory statements), these concerns must be detailed in the confidential comments to the editorial team.
  • In cases of doubt, the editorial office may contact the authors for clarification and, if necessary, request supporting materials (e.g., original and AI-modified files, primary data, search logs for reviews) to inform an editorial decision.

6.7. Indicators of AI Use
Reviewers should be alert to the following red flags, which may indicate poor or undisclosed AI assistance, requiring closer scrutiny:

  • Fabricated, incorrect, or non-existent references.
  • Misattributed or inadequately supported citations and claims.
  • Vague, imprecise, or templated descriptions of methodology or analysis.
  • Illogical flow, repetitions, or excessive verbosity ("text inflation").
  • Lack of context or an incomplete, non-critical literature review.
  • Suspected fabrication or falsification of data/methodology.
  • Inability to verify the study based on the provided information.
  • Authors' inability to provide substantive responses to critical technical questions about their work.
 
7. Dispute Resolution
7.1. In case of irreconcilable differences between the author and a reviewer, the editorial team may send the manuscript to another reviewer. In contentious situations, the final decision is made by the Editorial Board.

7.2. The final decision is made by the Editorial Board, considering the recommendations of the reviewers and the scientific editor. The Editor-in-Chief holds the ultimate decision-making authority in conflict situations.

 
8. Archiving of Reviews
8.1. The Editorial Office will submit copies of reviews to the Russian Ministry of Science and Higher Education upon official request. Original reviews are stored in the journal's office for 5 years.

8.2. Full texts of reviews for all published articles are uploaded to the scientific electronic library eLIBRARY.RU together with the article materials. These reviews are not publicly accessible, and reviewers' personal data remain confidential.

 

Publication Frequency

The journal publish regular issues quarterly, 4 issues per year.

 

Open Access Policy

Consortium PSYCHIATRICUM is an open access journal. All articles are made freely available to readers immediately upon publication.

Our open access policy follows the Budapest Open Access Initiative (BOAI) definition. It means that articles are freely available on the public internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from gaining access to the internet itself. For more information, see the full BOAI statement.


This journal's articles are licensed under Creative Commons NonCommercial-NoDerivates 4.0 International (CC BY-NC-ND 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

 

Archiving

The journal makes full-text archives on theи PubMed Central and on the Russian Science Electronic Library (eLibrary.ru) platform.

Also, the journal uses the PKP Preservation Network (PKP PN) to digitally preserve all the published articles. The PKP PN is a part of LOCKSS (Lots of Copies Keep Stuff Safe) program offers decentralized and distributed preservation, seamless perpetual access, and preservation of the authentic original version of the content.

 

Author Self-Archiving

The journal is compliant with Platinum Open Access mode for articles distribution.

You can find Articles Sharing Policy and Research Data Sharing Policy on the Publisher's webpage. Below you can find the journal's policy on self-archiving.

Terms and definitions

We use the following terms and definitions:

  • Preprint: An early version of an article prior to the version submitted for publication in a journal. Theses and dissertations are considered to be preprints.
  • SMUR (Submitted Manuscript Under Review): The version of the article that is under formal review for inclusion in the journal.
  • AM (Accepted Manuscript): The version of the article that has been accepted for publication. This version may include revisions resulting from peer review but may be subject to further modification by Eco-Vector (for example, copyediting and typesetting).
  • VoR (Version of Record): The version that is formally published. This not includes any Online First article that is formally identified as being published online before the compilation of a journal issue. The VoR includes any post-publication corrections.
  • Personal webpage: Web pages created by you, about you and your research which are hosted on a non-commercial website (such as your institute’s website). Personal profile pages in commercial sharing sites (such as ResearchGate, Academia.edu and Facebook) are not considered to be personal web pages.
  • Department or institutional repository: Web pages hosted by an academic or research institute or department to provide access to the work to promote and the activities of the institute or department, at all times operating for a non-commercial purpose.
  • Subject repository: Web pages hosted by an organization to provide access to the work from researchers working in a subject or range of subjects, at all times operating for a non-commercial purpose.
  • Commercial and non-commercialCommercial means any activity for direct or indirect financial gain. When considering whether a use is commercial or non-commercial, we look at the nature of the activity rather than the nature of the site or organization performing the activity.


What can be self-archived, where and when

 

 

Personal
web page

Department or institutional repository

Non-commercial subject repository
(e.g. PubMed Central)

Commercial repository or social media site
(e.g. ResearchGate, Academia.edu, SSRN)

Preprint,
SMUR

At any time

At any time

At any time

At any time

AM

At any time

At any time

At any time

At any time

VoR

At any time

At any time

At any time

At any time

 

Plan S compliance

Our Platinum OA policy is compatible with Plan S, and our License to Publish agreements with authors may not conflict with authors' agreements with their cOAlition S funders. 

Creative Commons and other end-user licenses

Preprints and SMURs can be made publicly accessible under any license terms the authors choose. We recommend a Creative Commons CC-BY or a more restrictive CC license.

Accepted Manuscripts can be made accessible under a Creative Commons CC-BY license or equivalent.

Third-party material

Before posting articles online, authors should ensure they have the appropriate permission to include any third party content. When posting articles under a Creative Commons license, the permission should allow the third-party material to be included either (i) under the Creative Commons license or (ii) clearly indicated as being protected by third party copyright, with a clear notice that it cannot be reused without further permissions clearance from the identified third-party rights holder.

Posting content in repositories

We require repositories to include:

  • If an article has not yet been published, a clear statement that the material has been accepted for publication in a revised form, with a link to the journal’s site on https://www.consortium-psy.com/.
  • For all published articles, a link to the article’s Version of Record in https://www.consortium-psy.com/ – for example, via a DOI-based link.
  • A clear statement about the license terms under which the posted version of the article is deposited.

Example statements are:

  • This article has been published in a revised form in Consortium Psychiatricum [http://doi.org/XXX]. This version is free to view and download for any purposes, re-distribution or re-use. © Authors.
  • This article has been published in a revised form in Consortium Psychiatricum [http://doi.org/XXX]. This version is published under a Creative Commons CC BY. Commercial re-distribution and re-use allowed. Derivative works can be distributed. © Authors.


Citing content in repositories

When citing an Accepted Manuscript or an earlier version of an article, we request that readers also cite the Version of Record with a DOI link, for example: Subsequently published in revised form in Consortium Psychiatricum [http://doi.org/XXX].

 

Publishing Ethics

1. Introduction1.1. The Editorial Board of Consortium PSYCHIATRICUM regards adherence to international standards of publication ethics as the cornerstone of trust in scientific knowledge. Our editorial policy is based on the principles of integrity, transparency, and respect for all participants in the scientific process. In its activities, the Editorial Board is guided by the recommendations of leading international organizations: the Committee on Publication Ethics (COPE), the International Committee of Medical Journal Editors (ICMJE), and the World Association of Medical Editors (WAME). Although the journal is not a formal member of these organizations, we fully endorse and apply the ethical norms and standards for scientific publications they have developed.

The ethical principles mandatory for authors, reviewers, and the Editorial Board are detailed in this section and form an integral part of the peer review and publication process for every manuscript.

1.2. The Editorial Board of Consortium PSYCHIATRICUM builds professional communication on a foundation of mutual respect. We expect our staff, authors, reviewers, and readers to adhere to the norms of ethical professional communication. In cases of aggression, harassment, bullying, or blackmail directed at editorial staff, the Editorial Board reserves the right to terminate communication.

2. Manuscript Requirements2.1. Authors must submit a manuscript containing reliable results and their objective assessment. The presentation of data and methodology must be sufficiently detailed to allow for verification and replication of the results. All statements and conclusions must be supported by data or references to authoritative sources.

2.2. When preparing literature reviews, authors are obliged to employ a systematic approach to the selection and analysis of sources and to ensure a balanced interpretation of the data presented therein.

3. Data Availability and Retention3.1. Authors are obliged to provide raw data and protocols upon the Editorial Board's request, ensuring their preservation for a reasonable period after publication, in accordance with the ALPSP-STM Statement on Data and Databases.

3.2. Data fabrication and falsification are considered unacceptable violations of scientific ethics.

4. Plagiarism4.1. Consortium PSYCHIATRICUM prohibits plagiarism in all its forms. This encompasses not only verbatim text copying but also the misappropriation of scientific ideas, hypotheses, methodologies, or results without appropriate credit.

4.2. Authors warrant that the submitted manuscript is an original work that has not been published previously and is not under consideration by another publication.

4.3. Any verbatim or near-verbatim borrowing of text, data, graphical materials, or ideas without proper citation of the original source is considered plagiarism. All forms of plagiarism are deemed a violation of publication ethics and constitute grounds for manuscript rejection.

4.4. Any borrowing from the authors' own previous works must be explicitly indicated and referenced to avoid self-plagiarism.

4.5. The publication of materials containing plagiarism is not permitted. If unauthorized borrowing or a low level of text originality is identified, the Editorial Board reserves the right to reject the manuscript or request its revision.

4.6. The Editorial Board checks the originality of all submitted manuscripts using the "Antiplagiat" system. Monitoring for plagiarism is also conducted during the peer review stage and after publication (based on reader appeals). If plagiarism is confirmed, the Editorial Board acts in accordance with the guidelines of the Committee on Publication Ethics (COPE). An article may be retracted at any time after publication.

4.7. AI-Generated Content and Authorship Misrepresentation
The use of AI tools to generate substantial portions of a manuscript without transparent disclosure and subsequent critical intellectual synthesis by the authors is unacceptable. Submitting such work is considered a severe breach of publication ethics, specifically plagiarism (of AI-generated content) and misrepresentation of authorship. Manuscripts identified as being substantially AI-generated will be summarily rejected.
If a manuscript is resubmitted without adequately addressing prior editorial concerns regarding improper AI use, it will be rejected unconditionally. In cases of deliberate or repeated violations, the journal reserves the right to take further action, which may include notifying the authors' institution(s) and imposing a ban on future submissions from the involved authors for a defined period.

5. Duplicate Submissions5.1. Authors must not submit a manuscript to more than one journal concurrently. This practice is strictly prohibited.

5.2. Publication of a manuscript presenting the results of a single study in multiple journals as an original work is not permitted.

5.3. Republication of certain types of articles (e.g., clinical guidelines, translated articles) in more than one journal may be considered ethical under specific conditions. Detailed criteria are outlined in the "Preprints and Reprints" section.

6. Acknowledgement of Sources6.1. Authors are obliged to provide references to all publications that have significantly influenced the submitted manuscript.

6.2. The use of information obtained from private sources (personal correspondence, conversations, discussions) is permitted only with explicit written permission.

6.3. It is prohibited to use confidential information (e.g., obtained during the peer review of manuscripts or grant application evaluations) without the direct written consent of the relevant authors or rights holders.

6.4. Editors and reviewers should only suggest references that improve the manuscript. They must not suggest references just to promote their own work, their colleagues' work, or journals they are connected to.

7. Article Correction and Retraction PolicyConsortium PSYCHIATRICUM maintains rigorous quality standards and implements thorough multi-stage evaluation of all manuscripts prior to publication. However, in rare instances following publication, corrections to content may be required or, as an ultimate measure, article retraction may be necessary.

7.1. Types of Corrections

The following modifications may be applied to published articles:

  • Addendum:new material expanding the original article's content (requires peer review).
  • Erratum: correction of errors introduced during the editorial/publication process.
  • Corrigendum:correction of author errors identified after publication.
7.2. Correction Procedures

7.2.1. Decisions regarding addendum publication are made by the Editorial Board based on recommendations from scientific editors or author requests.

7.2.2. Erratum is issued for errors, typically of a typographical or formatting nature, that were introduced by the journal during production and do not affect the readability, reproducibility, or core findings of the research.

7.2.3. For corrigendum publication, authors must submit a formal request detailing the error and proposed changes. The editorial team evaluates the impact of corrections on the article's scientific validity before approving their publication.

7.3. Article Retraction Guidelines

7.3.1. The journal may retract publications to alert readers to significant flaws or errors in published articles. Such errors may result from genuine oversight or deliberate author misconduct.

7.3.2. A manuscript may be retracted for the following reasons:

  • plagiarism;
  • data falsification (including image manipulation and result misrepresentation);
  • substantial errors in methodology, calculations, or data interpretation undermining core conclusions;
  • infringement of intellectual property rights, including copyright;
  • duplicate publication without proper attribution, notification, or permissions;
  • undisclosed use of AI tools in manuscript preparation;
  • major ethical violations (including undisclosed conflicts of interest affecting work evaluation).

7.3.3. Retraction decisions may be initiated through author request (with justification) or through editorial investigation. Authors are formally notified of retractions with stated reasons and effective dates.

7.3.4. The journal follows Committee on Publication Ethics (COPE) guidelines (https://publicationethics.org/) and recommendations from the Association of Science Editors and Publishers (ASEP) Ethics Council (https://rasep.ru/sovet-po-etike/pravilo-otzyva-retragirovaniya-stati-ot-publikatsii) in retraction cases.

7.3.5. Retracted articles remain accessible in their original issue with prominent "RETRACTED" watermarks on the text and table of contents. Retraction notices are published in the website news section. The editorial office notifies all indexing databases and repositories where the journal is indexed about retracted publications.

7.4. Changes Tracking

Consortium PSYCHIATRICUM supports CrossMark technology (Crossref) to track all post-publication modifications including corrections, addenda, updates, and retractions.

To verify any article's current status, click the CrossMark logo appearing on PDF versions.

8. Appeals and Complaints

The Editorial Board accepts and considers appeals and complaints from authors, reviewers, and readers regarding violations of editorial ethics, inappropriate borrowing, or non-compliance with publication standards.

8.1. Grounds for Appeal or Complaint

Appeals or complaints may be submitted in the following circumstances:

  1. Editorial decisions (challenging editorial decisions, such as manuscript rejection).
  2. Procedural delays (significant delays during peer review or scientific editing stages).
  3. Ethical concerns (including, but not limited to, issues of authorship, peer review integrity, or competing interests).
8.2. Submission Procedure

All appeals and complaints should be submitted to the official editorial email: editor@consortium-psy.com.

8.3. Review Process

8.3.1. Editorial Decisions
The Editorial Board conducts a reassessment of the manuscript, examining the author's arguments, reviewer feedback, and scientific editor's comments.

The review may result in one of the following outcomes:

  • uphold the original decision;
  • initiate additional independent peer review;
  • reverse the decision in the author's favor.

The appellant receives a written response with detailed explanations. Decisions on appeals are final and not subject to further review.

8.3.2. Procedural Delays
The situation is investigated by Deputy Editors-in-Chief.

The complainant receives a comprehensive explanation, and if violations are confirmed, the editorial office implements measures to improve workflow procedures.

8.3.3. Ethical Concerns
Investigations are conducted according to Committee on Publication Ethics (COPE) guidelines.

In complex cases, the editorial office may consult with the publisher or independent experts.

8.4. Final Provisions

The editorial office is committed to reviewing all submissions with maximum objectivity and impartiality. However, abuse of the appeals process is not permitted: repeated complaints on the same matter that do not present new substantial evidence will not be reconsidered.

9. Ethical Standards for Research Involving Human and Animal Subjects9.1. Consortium PSYCHIATRICUM will only consider manuscripts reporting work that complies with international bioethical standards, the principles of Good Clinical Practice (GCP), and all applicable legislative and regulatory requirements at all stages of the research.
9.2. In the "Methods" section, authors must disclose all potential risks to research participants associated with the use of pharmaceutical drugs, medical interventions, diagnostic procedures, and other actions that could affect their health and well-being.
9.3. Authors must provide information on the approval of the study by an ethics committee, indicating its full name, the protocol registration number, and the date of the meeting. Upon the Editorial Board's request, certified copies of the relevant documents must be provided.
9.4. For research involving human participants, voluntary informed consent must be obtained from all participants. In the case of publishing identifiable materials (photographs, video recordings, personal data), additional direct written permission from the patient is required.
9.5. Authors bear full responsibility for the confidentiality of personal data of research participants. Published materials must completely exclude any information that could allow the identification of patients or other participants in the study.

10. Authorship10.1. Definition of Authorship
10.1.1. In accordance with ICMJE recommendations, authorship credit should be based on the following four criteria:
• Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND
• Drafting the work or revising it critically for important intellectual content; AND
• Final approval of the version to be published; AND
• Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

10.1.2. Changes to the list of authors (addition/removal or change in the order of authorship) after the manuscript has been accepted for publication are not permitted.
10.1.3. Acquisition of funding, provision of resources, technical support, scientific supervision, or general leadership of the research group alone does not constitute grounds for authorship.
10.1.4. Contributors who do not meet all four criteria for authorship but have provided substantial assistance may be acknowledged in the "Acknowledgements" section, with their consent and a description of their specific contribution.
10.1.5. All individuals and organizations listed in the "Acknowledgements" section must provide the authors with written consent for the mention, as their names become associated with the research and its findings. While this consent does not need to be submitted to the Editorial Board with the manuscript, authors must be prepared to provide it upon request.

10.2. Corresponding Author
One author must assume responsibility for correspondence with the Editorial Board. Their duties include:
• Confirming that the list of authors accurately reflects their actual contribution to the research;
• Obtaining approval of the final version of the manuscript from all co-authors prior to publication;
• Keeping the team informed about the content of correspondence with the Editorial Board and reviewers.

10.3. Affiliations
The primary affiliation listed should be the institution where the majority of the research was conducted. Authors may optionally list other organizations with which they are professionally affiliated. Changes to affiliations are not permitted after the article is published.

10.4. Changes in Authorship
10.4.1. Before submitting a manuscript to the journal, authors must finalize the composition of the author team, appoint a corresponding author, and determine the order of authors.
10.4.2. Changes to the list of authors during the review stage are permitted only in exceptional cases and require mandatory justification and approval by a Deputy Editor-in-Chief.
10.4.3. After a manuscript is accepted for publication, changes to the list of authors are not permitted. Authors' names are published according to the data provided in the final version of the manuscript.

10.5. Author Name Change
Authors who have changed their personal data (surname or given name) have the right to request a correction in previously published articles. The Editorial Board offers two options for implementing changes:
• Without formal notification – edits are made directly to the electronic versions of the article (PDF and HTML);
• With formal notification – a Corrigendum is published explaining the changes made.

10.6. Authors Unable to Participate in the Editorial Process
In the event of the death or loss of legal capacity of a co-author during the preparation, submission, or review of a manuscript, the decision to retain their name in the list of authors is made by the remaining members of the team. This requires the written consent of a legal representative (e.g., a next of kin).

10.7. Resolution of Authorship Disputes
10.7.1. The journal does not act as an arbiter in conflicts between authors during the review stage or after publication of an article. Authors are strongly encouraged to resolve such situations independently.
10.7.2. If authors are unable to reach an agreement, the journal reserves the right to:
• Withdraw the manuscript from the editorial process (for unpublished materials);
• Refer the matter to the authors' institutions for resolution (for published articles).
10.7.3. The journal's final decision will be based on the findings and recommendations of the institutions. Disputed issues are considered on a case-by-case basis, taking into account all the circumstances of the specific case.

11. Responsibilities of the Editorial Process Participants

11.1. Responsibilities of the Editorial Board
11.1.1. The Editor-in-Chief and the Editorial Board are responsible for:
• Formulating and implementing the journal's publication policy in accordance with international ethical standards (COPE, ICMJE, WAME);
• Making the final decision on the publication or rejection of manuscripts based on their scientific significance, originality, and relevance to the journal's scope;
• Ensuring the impartiality and objectivity of the editorial process, excluding influence from the authors' race, ethnicity, gender, religious beliefs, citizenship, or political preferences;
• Considering author appeals and resolving disputes related to the peer review and acceptance of manuscripts;
• Organizing a timely peer review process, selecting competent reviewers, and monitoring the deadlines for providing reviews;
• Identifying conflicts of interest and taking measures to eliminate them at all stages of the editorial process;
• Making decisions on the retraction of published articles in cases of gross violations of publication ethics.

11.1.2. The Editors (Scientific Editors, Copy Editors) are responsible for:
• Strictly maintaining confidentiality regarding the content of the manuscript, information about the authors, and reviewers at all stages of work;
• Objectively analyzing reviews and preparing reasoned conclusions for authors and the Editorial Board;
• Interacting with authors based on the principles of professionalism, respect, and professional ethics;
• Promptly informing the Editor-in-Chief of any potential conflicts of interest related to the manuscript;
• Ensuring the high scientific and stylistic quality of published materials within their competence.

11.2. Responsibilities of the Reviewer
Peer review is a key stage of the editorial process, ensuring the high quality, accuracy, and clarity of published materials. Reviewers assist the Editorial Board in making an informed decision on publication and help authors improve their articles by incorporating professional feedback.
Reviewers serve as independent experts: their constructive assessment helps maintain the journal's scientific standards.
For more details on the peer review procedure and reviewer responsibilities, please see the "Peer Review" section.

11.3. Responsibilities of the Authors
Authors bear full responsibility for the content of the manuscript and undertake to adhere to the following principles.

11.3.1. Compliance with Guidelines and Deadlines
Authors must strictly adhere to all stipulated requirements: manuscript formatting rules, instructions contained in editorial letters (including established deadlines), and the procedure for addressing comments from reviewers and scientific editors. Failure to meet these requirements is considered a violation of publication ethics and leads to editorial sanctions.

11.3.2. Scientific Integrity and Reliability
Authors guarantee:
• The reliability of the presented results and the conformity of the research methodology to accepted standards;
• Provision of raw data to the Editorial Board upon a reasoned request;
• The originality of the work, the absence of plagiarism in any form, and the proper formatting of all cited sources.

11.3.3. Publication Ethics
• Authors confirm that the manuscript is not under consideration by other publications and has not been published previously.
• The list of authors includes all persons who made a significant contribution to the research and complies with international authorship criteria.
• Authors undertake to disclose all potential conflicts of interest that could affect the interpretation of the results, indicate sources of funding, and report the use of artificial intelligence technologies in the preparation of the work.

11.3.4. Interaction with the Editorial Board
• Authors undertake to diligently and within the established deadlines make revisions to the manuscript based on the reviewers' comments.
• Authors are obliged to maintain the confidentiality of information received during the editorial process (e.g., from reviewers) and not to use it for other purposes without official permission.

11.4. Responsibilities of the Publisher
11.4.1. The Publisher is obliged to:
• Ensure adherence to ethical norms by the editors, reviewers, and authors of Consortium PSYCHIATRICUM in accordance with established requirements;
• Exclude the influence of commercial interests (including revenue from advertising or reprints) on editorial decisions.

11.4.2. The Publisher is obliged to assist the editors of Consortium PSYCHIATRICUM in handling ethical complaints regarding published materials and to facilitate their interaction with other journals and publishers to effectively fulfill editorial duties.

11.4.3. The Publisher is obliged to promote adherence to proper research practice and the implementation of industry standards aimed at improving ethical norms, as well as procedures for retracting and correcting publications.

11.4.4. The Publisher is obliged to ensure the provision of specialized legal support (including consultation and preparation of opinions) in cases requiring legal assistance.

The section is prepared according to the files of Elsevier publisher and files from Committee on Publication Ethics (COPE).

 

Article processing charges

There are no article processing charges (APCs) for authors.
All services, including scientific editing, copyediting anf proofreading, translation, NLM reference formatting, typesetting, promotion, and a printed author copy of the journal, are provided free of charge.

 

Artificial Intelligence

The Editorial Board of Consortium PSYCHIATRICUM acknowledges the potential of Artificial Intelligence (AI) technologies to enhance the scientific process. AI can accelerate research, improve knowledge accessibility, and optimize routine tasks. However, we are also mindful of the associated risks, such as the generation of plausible but inaccurate or biased information, threats to data confidentiality, and the dissemination of misinformation.

This policy governs the use of AI technologies (including generative language models (LLMs), machine learning tools, and algorithmic systems) at all stages of preparing, reviewing, and editing scholarly materials submitted to Consortium PSYCHIATRICUM. The policy applies to all participants in the editorial process (authors, reviewers, editors, and editorial staff) and covers all types and formats of submitted materials (text, images, data, etc.).

1. AI guidelines for research authors 

Consortium PSYCHIATRICUM permits the use of AI technologies as an auxiliary tool in manuscript preparation, provided authors adhere to the following key requirements:

  • Authors bear full and sole responsibility for the entire content of their work (text, data, conclusions, ethical compliance), regardless of the extent of AI use. All content created or processed with AI must be meticulously verified and edited by the authors. AI cannot be listed as an author or cited as an information source.
  • Authors must inform the Editorial Office about the use of AI as a research tool, for text refinement, or for creating illustrations. The description should be sufficiently detailed to assess the authors' intellectual contribution and ensure reproducibility. Upon request, authors must provide original and AI-modified materials, as well as primary data.
  • Authors must comply with the terms of service of AI tools, ensure data confidentiality, and account for potential risks of systematic bias.

The complete guidelines are available in the Instructions for Authors. 

2. AI guidelines for reviewers

Reviewers are prohibited from uploading manuscripts, parts of manuscripts, or review texts containing confidential information into public AI services, as this violates the confidentiality of materials under consideration.

Permitted use of AI is limited to auxiliary tasks, such as structuring a review outline, performing language editing on already written text, or consulting on general methodological questions without disclosing details of the specific manuscript.

Any other use of AI, particularly for analyzing manuscript content, requires prior written permission from the Editorial Office.

The reviewer's primary task is to evaluate the novelty, relevance, practical significance, and scholarly merit of the work. The mere fact of AI use by authors is not an evaluation criterion; reviewers must assess the completeness and accuracy of the authors' disclosure. If justified suspicions arise regarding improper or undeclared AI use, the reviewer must detail these concerns in the confidential comments for the Editor to initiate a professional dialogue with the authors.

The full set of rules, including indicators of improper AI use and reviewer procedures, is outlined in a separate Guide for Reviewers.

3. AI guidelines for editors 

Editors of Consortium PSYCHIATRICUM are responsible for the scientific quality of published works and must ensure the confidentiality of manuscripts under review.

  • Editors may request from authors the original data, prompts, and intermediate files to verify the authors' intellectual contribution and confirm that AI use has not distorted results or compromised research integrity.
  • The use of public AI services (e.g., ChatGPT, DeepSeek) for analyzing manuscripts, reviews, author data, or for making editorial decisions is prohibited. Uploading such information to third-party systems is unacceptable.
  • Permitted use includes employing authorized internal journal/publisher AI tools and approved third-party software for auxiliary checks of text and images for plagiarism and other breaches of research and publication ethics. In such cases, the responsibility for ensuring the confidentiality and copyright of transferred materials and personal data lies with the service providers.
  • The use of any tools, including internal systems, does not absolve the Editor of responsibility for all edits, decisions, and the content of published materials, which must be based on professional expert judgment.
4. AI guidelines for the editorial staff

Editorial Office Staff are authorized to:

  • Use AI tools to generate auxiliary content (e.g., brief summaries, social media posts, podcasts).
  • Use a specifically developed, internal AI tool for the preliminary technical check of submitted manuscripts for compliance with the journal's formal requirements.
  • Reject a manuscript at any stage of the publication process if undeclared or unethical use of AI is identified, including data fabrication, plagiarism, inappropriate text recycling, or the generation of unreliable content.
  • Employ AI-detection tools as an auxiliary measure in exceptional cases to identify potential breaches of this policy.

 

EQUATOR Network Reporting Guidelines

The editorial board of Consortium PSYCHIATRICUM strongly recommends that authors use the EQUATOR Network publication guidelines when preparing manuscripts. A unified standard for reporting research ensures the accuracy, completeness, and transparency of articles. As a result, the scientific reliability and value of published materials are significantly enhanced.

1. Manuscripts describing original research (including study protocols and systematic reviews) must be submitted to the editorial office in strict accordance with the structure of the checklist from one of the reporting guidelines available in the EQUATOR Network For most studies, one of the following guidelines will be appropriate:

2. The list above is not exhaustive. If no listed guideline is appropriate for your research, you must identify a suitable alternative using the search function of the EQUATOR Network library (searchable by study type, clinical area, manuscript section, or keywords).

3. Authors who need help selecting an appropriate guideline may contact the editorial office at editor@consortium-psy.com for guidance.

4. The editorial team will check for guideline adherence during initial manuscript screening. If a manuscript is submitted using an incorrect or inappropriate guideline, the authors will be requested to revise and resubmit it using the correct checklist.

5. For any checklist item that is not applicable to the study, authors must mark it as "Not applicable." The item header must be retained in the text. All non-applicable items will be removed by the editorial staff during the final typesetting stage prior to publication.

For detailed instructions on how to select and use these guidelines, please read our guide.

 

Online First publications

The Online First section features articles that have been approved for publication by the editorial board following peer review and scientific editing. These materials have completed full pre-publication preparation, including copyediting, translation, proofreading by a native speaker, reference list verification, and final approval of the text and layout by the authors. These articles will be included in one of the journal's forthcoming issues.

Online First articles are published under open access license, which permits users to read, download and share them without restriction. These materials can be cited the same way as publications from the journal's regular issues. A complete citation record is provided at the end of each article's PDF file.

Since the Online First version constitutes the final version of the article, no further revisions can be made to it. Any necessary changes will be published separately as “addendum” or correction (“erratum”/“corrigendum”) in a subsequent journal issue

 

Editorial process

Manuscripts submitted to the editorial office undergo several stages of review:

Check the video on the editorial process: https://www.youtube.com/watch?v=-qzBprwRVnk

1. Technical Check

Upon submission, each manuscript undergoes an initial technical assessment to ensure it meets the journal's formal requirements:

  • Scope: The work must fall within the field of psychiatry and related disciplines.
  • Originality: The text is screened using the "Antiplagiat" system to identify plagiarism.
  • Structure: The manuscript must adhere to the structure outlined in the relevant EQUATOR Network guideline for the declared study type.
  • Use of artificial intelligence (AI): Manuscripts are screened for AI-generated content using dedicated detection tools. If potential AI generation is identified, the editors request primary data, drafts, screenshots, or other documentation from the authors to verify their substantive contribution and the extent of AI use (e.g., for editing, translation, or analysis). Manuscripts found to have been entirely generated by AI, without substantial intellectual input from the authors, will not be considered for peer review. Authors must disclose any use of AI tools in the preparation of their manuscript within a dedicated "Generative AI Use Statement" section.

The technical check is completed within 3 business days.
Submissions that do not fulfill all requirements will be either returned to the authors for amendment or declined.
Articles that fulfill all formal requirements are forwarded to the Editorial Board for consideration.

2. Editorial Board Assessment

During the initial editorial assessment, the Scientific Editor evaluates the manuscript's scientific novelty, methodological validity, and adherence to ethical standards. Based on this assessment, the manuscript may be returned to the authors for amendment, accepted for further processing (sent for peer review and scientific editing), or declined.

3. Peer Review and Scientific Editing

3.1. Peer review is a crucial component of the editorial process at Consortium PSYCHIATRICUM. The journal's peer review policies and procedures are outlined in a dedicated section.
3.2. The Reviewer evaluates the scientific quality and rigor of the manuscript, while the Scientific Editor assists the authors in improving its structure, clarifying the objectives, methods, and results, and strengthening the logical flow. A Statistical Editor verifies the accuracy of calculations and the validity of the chosen analytical methods in studies.
3.3. The editorial office sends the Reviewer's and Scientific Editor's comments (and, if applicable, the Statistical Editor's comments) to the author. The author revises the manuscript, providing a response to every remark and incorporating the necessary edits into the text. Authors are given 2 weeks to submit revisions; this period may be extended upon request.
3.4. The Scientific Editor and the Reviewer examine the revised manuscript and may ask the authors for clarifications if needed. This constitutes one round of review; the manuscript may undergo up to four such rounds. After each round, the reviewer and Scientific Editor make one of the following decisions: request further revisions or recommend the article for publication.

4. Final Editorial Board Decision

Manuscripts that have received positive recommendations from the Reviewer and Scientific Editor are submitted to the Editorial Board for final consideration. The Board members conduct a final assessment and make the ultimate decision to accept the manuscript for publication or to request additional clarifications from the authors.

5. Appeals

5.1. Authors have the right to appeal a decision made by a Reviewer and/or the Scientific Editor by submitting a formal appeal to the editorial office (see Appeals and Complaints).
5.2. If the authors refuse to revise the manuscript based on the comments from the Reviewer and/or Scientific Editor, they must notify the editorial office in writing of their decision and provide a justification.

6. Withdrawal of Manuscripts

6.1. If the authors do not return the revised version of the manuscript within 3 months from the date the review and/or editorial comments were sent, the editorial office will withdraw it from consideration (even in the absence of a formal withdrawal notice from the authors). In such cases, the authors will be notified accordingly that the manuscript has been withdrawn due to the expiration of the revision period.
6.2. Failure to adequately address the essential concerns of the Reviewers and/or Scientific Editor will result in the manuscript's withdrawal from consideration.

7. Preparing for Publication

7.1. Accepted manuscripts undergo copyediting. At this stage, authors may be required to provide necessary clarifications.
7.2. The finalized manuscript is translated into English (or Russian), after which the translation quality is verified by a native speaker.
7.3. A bibliographer formats the reference list according to the NLM style.
7.4. A designer performs the text layout and creates illustrations (graphs and charts) that meet printing-quality standards.
7.5. The final PDF version of the article (in both Russian and English) is proofread by a native speaker and a copy editor, and is then sent to the authors for final approval. After this stage, corrections can only be made via publishing an erratum/corrigendum.
7.6. The approved version of the article is published on the journal's website as an Online First article. The article is available in open access in full-text format, is citable, and can be referenced.
7.7. Articles from the Online First section are published in one of the journal's subsequent regular issues.

 

Reprints Policy

1. IntroductionA reprint is a high-quality printed copy of an article in the format of a separate booklet, identical to the final version published on the journal's website.

2. How to order reprint
  • Reprint orders are accepted only after the official online or print publication of the article.
  • All orders must be placed directly with the Editorial Office of the journal (E-mail: editor@consortium-psy.com).
  • A reprint request must contain the full bibliographic reference of the article, the desired print run, and the delivery address.
  • The journal does not process reprint orders received from third parties (e.g., printing companies) without direct prior authorization from the author(s) or the copyright holder.
3. Copyright and Permissions
  • Ordering and distributing reprints does not constitute a transfer of copyright for the article.

  • By placing an order, the author/organization confirms that the reprints will be distributed for non-commercial, educational, or scientific purposes, unless otherwise agreed upon with the Editorial Office.

4. Mandatory Requirements for Reprints
Each reprint copy must mandatorily include:
  • The full bibliographic reference (authors, title, journal, year, volume, issue, pages, DOI).

  • The logo and name of the Consortium PSYCHIATRICUM journal.

  • The copyright notice: "©Eco-Vector, [Year]. Published in Consortium PSYCHIATRICUM. All rights reserved."

  • A disclaimer, if the article contains clinical trial data: "This information is intended for healthcare and pharmaceutical professionals. It is not promotional material for a medicinal product. Please consult a healthcare professional before use."

  • It is prohibited to make any alterations to the text, graphics, or conclusions of the reprint. The addition of commercial promotional material (sponsor logos, drug names) onto the pages of the article itself is forbidden without the explicit permission of the Editorial Office. Commercial information may only be placed on a separate promotional insert or cover, clearly distinct from the scientific content.

5. Liability
The Editorial Office of Consortium PSYCHIATRICUM is not liable for the content of any advertisements or promotional materials placed by third parties in reprints, nor for the interpretation and use of the article's scientific data following its distribution in reprint form.

 

Republications

1. General principles

In exceptional cases, the Editorial Board of Consortium PSYCHIATRICUM may consider the republication of an article previously published in another peer-reviewed journal. We take this step only if it provides substantial value to our readership — for example, by introducing a key work on an important topic that was previously unavailable in Russian or English. Our guiding principles remain strict adherence to copyright, full transparency, and the avoidance of duplicate publication without compelling justification.

2. Procedure

Republication is permitted only if all the following conditions are met simultaneously:

  • Permission from the copyright holder. Official written permission must be obtained from the publisher (copyright holder) and the Editor-in-Chief of the source journal. The permission must explicitly grant the right to reprint the article in Consortium PSYCHIATRICUM.
  • Consent from all authors. Each and every author of the original article must provide direct written consent for republication in our journal.
  • Attribution of the original source. The article must be accompanied by the following statement on its first page:

"This article was originally published in [Language] in [Full Journal Name], [Year], [Volume], [Issue], [Pages]; DOI: [Link]. Reprinted with permission from [Name of Copyright Holder]."
The reference list must cite this original publication as the first and primary reference.

3. Format
  • The article is republished without alterations to its scientific content, data, or conclusions. The Editorial Board may adapt the translation style and formatting to align with the journal's standards.
  • The addition of a foreword from the editors, an afterword from the authors, or an updating commentary is permitted. Such material must be clearly separated from the main text and signed.
  • The republished article undergoes internal editorial review but is typically not sent for additional peer review unless substantial additions or changes have been made.
4. Ethical restrictions
  • The Editorial Board does not permit republication where the primary aim is to artificially inflate bibliometric indicators (impact factor, citation counts) for authors or the journal.
  • Authors must not present the republished article as an "original" work in reports, grant applications, or publication lists.
  • The Editorial Board reserves the right to deny a republication request without providing a reason, particularly if there are doubts regarding its necessity, the transparency of the process, or compliance with ethical standards.
5. Republication of articles from Consortium PSYCHIATRICUM in other journals

To republish an article originally published in Consortium PSYCHIATRICUM in any other journal, the following is required:

  • Submit an official request to the Editorial Board.
  • Obtain written permission, the terms of which (including any potential licensing fees) are determined on a case-by-case basis.
  • Guarantee adherence to all principles analogous to those outlined in this policy: clear attribution of the original source, consent from authors, no alterations to content, and clear demarcation between the scientific text and any supplementary materials.
  • Provide the Consortium PSYCHIATRICUM Editorial Board with the final version of the material prior to its publication to confirm the correct formatting of the reference to the original source.

 

Adverticement and reprint policy

Our advertising policy is consistent with the principles mentioned in the Recommendations on Publication Ethics Policies for Medical Journals which issued by the World Association of Medical Editors (WAME).

http://www.wame.org/recommendations-on-publication-ethics-policie

  1. The Eco-Vector’s journals generate revenue from advertising, which creates a potential conflict of interest. Editors’ decisions do not depend on the cost of advertising or producing reprints. Advertisers and sponsors have no influence over the editor’s decisions, regardless of the terms of advertising or other agreements.
  2. All advertisements are subject to the approval of the Eco-Vector’s staff, which reserves the right to reject or cancel any advertisement at any time.
  3. The functions of editors and advertising managers in Eco-Vector’s journals are separate.
  4. In Eco-Vector’s journals professional (physician-directed) publications and web sites, the intentional placement of advertising adjacent to articles discussing the company or product that is the subject of the advertisement is prohibited. Advertising content must be distinguished from editorial and other materials so that the difference between them is obvious.
  5. Eco-Vector will not publish “advertorial” content, and sponsored supplements must be clearly indicated as such. If a supplement did not undergo peer review or underwent a peer review-process different from the rest of the journal that should be explicitly stated.
  6. All Eco-Vector’s journals have the right to refuse any advertisement that, in its sole discretion, is incompatible with its mission or inconsistent with the values of members, the publication/web site or the organization as a whole, and to stop accepting any advertisement previously accepted. Advertisements are subject to review by the editors and others at the Eco-Vector’s journals. In no case shall separate agreements with Eco-Vector’s journals or its subsidiaries supersede this policy.
  7. Once an advertisement has been deployed online, it will be withdrawn from the journal site at any time if the Editor(s)-in-Chief or Eco-Vector’s staff request its removal.
  8. Advertising for the following categories is prohibited:
    • Alcohol
    • Tobacco
    • Weapons, firearms, ammunition
    • Fireworks
    • Gambling and lottery
    • Pornography or related themes
    • Political and religious advertisements
    • Advertisements that claim to have a “miracle” cure or method
    • Advertisements that make unsubstantiated health claims for the products advertised
    • Advertisements directed at children
  9. Advertisements may not be deceptive or misleading, and must be verifiable. Advertisements should clearly identify the advertiser and the product or service being offered. Exaggerated or extravagantly worded copy will not be allowed. Advertisements will not be accepted if they appear to be indecent or offensive in either text or artwork, or if they relate to content of a personal, racial, ethnic, sexual orientation, or religious nature.
  10. All advertisements are accepted and published by Eco-Vector on the warranty of the advertisement agency and advertiser that both are authorized to publish the entire contents and subject matter of the advertisement.
  11. In consideration of publication of an advertisement, the advertiser and the advertisement agency, jointly and severally, agree to indemnify and hold harmless Eco-Vector, its officers, agents and employees against expenses (including legal fees) and losses resulting from the publication of the contents of the advertisement, including, without limitation, claims or suits for libel, violation of privacy, copyright infringement, or plagiarism.
  12. Any references to Eco-Vector or its products or services in advertisements, promotional material, or merchandising by the advertiser or agency is subject to Eco-Vector’s written approval for such use.
  13. All advertisements for drug-specific campaigns must comply with the relevant Russian legislation that regulates advertising. Advertisers should make available to Eco-Vector the marketing authorization and summary of product characteristics when submitting their advertisement. In the case of drug advertisements, proprietary names of pharmaceutical products must be accompanied by the chemical, generic, or official name; the quantity of all active substances must be stated along with the recommended dosage. Each page of an advertisement for a prescription-only medicine should be clearly labeled as intended for health professionals.
  14. Advertisements for products not approved by the FDA or the Ministry of Health of Russian Federation that make any kind of health claims must carry the following disclaimer: “These statements have not been evaluated by the Food and Drug Administration and/or the Ministry of Health of Russian Federation. This product is not intended to diagnose, treat, cure or prevent any disease.”
  15. While Eco-Vector’s journals welcomes and encourages information-rich advertising, advertisements, advertising icons and advertiser logos must be clearly distinguishable from editorial content and may require special labeling to distinguish them as such. All advertisements must clearly and prominently identify the advertiser by trademark or signature.
  16. Reprints should be published only in the form in which they were originally published in the journal (including subsequent corrections), so there should be no additions or changes in them.
  17. Publisher is not responsible for incidental or consequential damage for errors in displaying or printing an advertisement.
  18. Advertisements may not imply endorsement by the Eco-Vector’s journals or its publications/web sites except as may be provided for under a separate agreement — in which case advertising must be pre-approved to ensure adherence to the letter and spirit of that separate agreement.
  19. The full rules for any market research or promotion associated with an advertisement must be displayed in the advertisement or available via a prominent link.
  20. The following online advertising formats are prohibited:
    • Pop-ups and floating advertisements.
    • Advertisements that collect personally identifiable information from visitors without their knowledge or permission.
    • Advertisements that extend across or down the page without the visitor having clicked or rolled-over the advertisement.
    • Advertisements that send visitors to another site without the visitor having clicked the advertisement.

Eco-Vector’s journals published advertising policies are not exhaustive and are subject to change at any time without notice.

We partner with third-party advertising companies to serve ads and/or collect certain information when you visit our website. These companies may use cookies or web beacons to collect non-personally identifiable information [not including your name, address, email address or telephone number] during your visit to this website to help show advertisements on other websites also likely to be of interest to you.

For contact with the Advertisement department of the Publisher, please, use email adv@eco-vector.com or follow the URL: https://eco-vector.com/